Our present study has shown that CCL18 reduces the expression of miR98 and miR27b in breast cancer cells via the N-Ras/ERK/PI3K/AKT/NFκB/Lin28b signaling cascade. This evidence concerns the gene AKT1 and breast carcinoma.